CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls Chong WangJing ChenYanfang Liu Original Article 07 September 2014 Pages: 181 - 185
Detection of dicentric chromosome (9;20) in paediatric B-cell acute lymphoblastic leukaemia: prognostic significance Mathilde LetouzeyDominique PentherPascale Schneider Original Article 06 September 2014 Pages: 187 - 193
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age Paola FinsingerMassimo BrecciaRoberto Latagliata Original Article 04 September 2014 Pages: 195 - 200
Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation Sha YiLu WenYan Chen Original Article 23 September 2014 Pages: 201 - 210
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution Hsin-An HouYun-Chu LinHwei-Fang Tien Original Article 21 September 2014 Pages: 211 - 221
Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage Peter ValentJörg BergerMichel Arock Original Article 11 September 2014 Pages: 223 - 231
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes Juliana SchwaabMarcin KnutAndreas Reiter Original Article 27 September 2014 Pages: 233 - 238
Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients Pengpeng XuDong YuWeili Zhao Original Article 06 September 2014 Pages: 239 - 247
Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinib David D. SmithLeanne GoldsteinFong Clow Original Article 03 September 2014 Pages: 249 - 256
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients Gang AnXiaoqi QinLugui Qiu Original Article 18 September 2014 Pages: 257 - 264
Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation Michaela DöringKarin Melanie RohrerGunter Kerst Original Article 13 August 2014 Pages: 265 - 273
Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia Ji Eun JangSoo Jeong KimYoo Hong Min Original Article 20 August 2014 Pages: 275 - 282
Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation—a single center experience Thomas HeinickeHeiko HüttenThomas Fischer Original Article 21 August 2014 Pages: 283 - 287
Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors Takaaki KonumaSeiko KatoSatoshi Takahashi Original Article 03 September 2014 Pages: 289 - 296
Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia Heidrun BoztugMarco Zeccaon behalf of the EBMT paediatric diseases working party Original Article 19 September 2014 Pages: 297 - 306
DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells Sevim IsikMerve ZaimGuven Cetin Original Article 13 September 2014 Pages: 307 - 318
Enhanced human mesenchymal stem cell survival under oxidative stress by overexpression of secreted frizzled-related protein 2 gene Kanjana PomdukPakpoom KheolamaiSurapol Issaragrisil Original Article 23 September 2014 Pages: 319 - 327
Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study Ilana KopolovicAgnes Y. Y. LeeCynthia Wu Original Article 05 September 2014 Pages: 329 - 336
Fulminant thrombotic thrombocytopenic purpura (TTP): association with amphetamine consumption? Jonathan de FalloisRalf RegenthalSirak Petros Letter to the Editor 04 June 2014 Pages: 337 - 338
Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis Nicola PolverelliLucia CataniFrancesca Palandri Letter to the Editor 04 July 2014 Pages: 339 - 341
HFE-related hemochromatosis risk mutations in Latvian population Raitis PeculisBaiba LaceJanis Klovins Letter to the Editor 13 July 2014 Pages: 343 - 344
A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation? Konstantin SchlickMarlene TrochGeorg Hopfinger Letter to the Editor 24 July 2014 Pages: 345 - 346
Unusual relapse of an angioimmunoblastic T cell lymphoma 11 years after initial manifestation Philipp LohneisChristian JakobIoannis Anagnostopoulos Letter to the Editor 13 June 2014 Pages: 347 - 349
Extramedullary relapse after accidental head injury in a patient with multiple myeloma Maximilian MerzLeonille SchweizerJens Hillengass Letter to the Editor 29 June 2014 Pages: 351 - 353
Extensive toxic epidermal necrolysis following brentuximab vedotin administration Maria Ilaria Del PrincipeGiuseppe SconocchiaAdriano Venditti Letter to the Editor 02 July 2014 Pages: 355 - 356
Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma Jennifer EatridesZachary ThompsonSamir Dalia Letter to the Editor 19 July 2014 Pages: 357 - 358
Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease Dominik BettingerElisabeth SchorbPeter Hasselblatt Letter to the Editor 13 July 2014 Pages: 359 - 360